StockStory Highlights Samsara (IOT) as Buy, Cautions on MGP Ingredients (MGPI) and ANI Pharmaceuticals (ANIP)

Investment research platform StockStory identified Samsara Inc. (NYSE: IOT) as a cash-producing stock expected to outperform, while advising caution on MGP Ingredients, Inc. (NASDAQ: MGPI) and ANI Pharmaceuticals, Inc. (NASDAQ: ANIP). The analysis, published January 26, 2026, is based on free cash flow margins and valuation metrics. Samsara, trading at $32.12 per share or 10.3x forward price-to-sales, was highlighted for its 12.8% trailing free cash flow margin. MGP Ingredients, at $25.16 per share and 11x forward P/E, and ANI Pharmaceuticals, at $82.97 per share and 11x forward P/E, were noted for their 10.7% and 18.8% cash flow margins, respectively, but flagged for potential underperformance. The platform's "Top 6 Stocks" list claims a 244% return over the past five years.